Industry
V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines
September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis Biosciences, a privately held life sciences company with an integrated […] September 20, 2023 · V-Bio VenturesAugustine Therapeutics expands its leadership team and R&D platform, enters regulatory development.
Leuven, Belgium, September 12th, 2023 – Augustine Therapeutics, a biotech company developing innovative therapies for neuromuscular and neurodegenerative disorders, announced […] September 12, 2023 · Quality by Design - Business & CommunicationsV-Bio Ventures portfolio company Corteria Pharmaceuticals raises EUR 65 million to advance its transformational medicines for cardiovascular diseases
Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio company, is a biopharmaceutical company specialized in the […] September 7, 2023 · V-Bio Ventures
Jan Rabaey on the convergence of biology and technology
Belgian Prof. Jan Rabaey has spent the past 35 years conducting pioneering tech research at the University of California at […] August 23, 2023 · BioVox
Johan Cardoen’s hopes for the future of agriculture
Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure […] August 23, 2023 · BioVox
Fermenting a more sustainable future
In the battle against the climate crisis, precision fermentation presents a hopeful aid. Using microbes to create valuable materials, we […] August 23, 2023 · V-Bio Ventures
Biodevice-CRO: smart solutions for better bioprocessing
Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership […] August 23, 2023 · MEDVIA
Bar.on presents the world’s first beer printer
Instantly turning water into beer may sound like a biblical miracle, but that’s exactly what Belgian start-up Bar.on is now […] June 21, 2023 · BioVox
The obesity revolution: will new drugs bring about big changes?
The recent approval of the obesity and diabetes drugs Wegovy, Ozempic, and Mounjaro has brought about big headlines, but are […] June 21, 2023 · V-Bio Ventures
Career opportunities in the life sciences industry
The pharma, biotech and medtech industries offer a wealth of job and career opportunities, but recent graduates and early-career professionals […] June 21, 2023 · BioVox
Advancing the pharmaceutical supply chain using artificial intelligence
Rapidly spreading diseases and unpredictable global shifts cause increased strain to the pharmaceutical supply chain, jeopardizing the secure delivery of […] June 21, 2023 · Janssen Pharmaceutica
The QbD Group acquires Turnstone Communications and BioVox to strengthen its specialist science communication and marketing services
Wilrijk/Ghent, Belgium, 25 May 2023 – The QbD Group, a privately held company offering comprehensive support to life science companies […] May 25, 2023 · Quality by Design - Business & Communications
OHMX.bio: state-of-the-art omics solutions
OHMX.bio provides innovative omics solutions using state-of-the-art sequencing and mass spectrometry platforms. Specializing in expression analysis (RNA-seq and RIBO-seq) and […] May 24, 2023 · MEDVIA